Canada is facing a nationwide shortage of these prescription painkillers
Global News
Two types of painkillers are experiencing a nationwide shortage in Canada, leading Health Canada to advise patients to consult doctors and pharmacists for alternatives.
A national shortage of common prescription pain medications in Canada could last into early August.
Health Canada issued a notice last week that drugs containing acetaminophen with codeine or oxycodone that are used to relieve pain are experiencing shortages.
Acetaminophen with oxycodone is often under the brand Percocet, while acetaminophen combined with codeine is sometimes known as Tylenol No. 3.
Other formulations include Teva-Oxycocet, Teva-Lenoltic No. 1, 2, 3 and 4, and Rivacocet.
Some of the companies that manufacture both medication combinations, including Teva Canada Ltd., Laboratoire Riva Inc. and Pharmascience Inc., have reported issues around manufacturing disruptions and increased demands as causes of the shortages.
The Canadian Pharmacists Association told Global News it’s been working with Health Canada and is in communication with manufacturers and suppliers to assess the potential impact.
In response to the shortages, the CPA said pharmacists have been limiting amounts given to patients.
“Usually pharmacists have to dispense the amount that is being written on the prescription unless it is being limited by the drug plan,” said Sadaf Faisal, senior director of professional affairs at the CPA.
